Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREAT: Azithromycin vs Erythromycin for PPROM
NCT03060473Phase 3Terminated
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Feb 2017
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin in preterm premature rupture of membranes (pPROM), sponsored by The University of Texas Medical Branch at Galveston. Started Feb 2017; status: terminated.
02
Drugs
azithromycin
03
Conditions
preterm premature rupture of membranes (pPROM)
Beyond the preview
Go deeper on NCT03060473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03060473.